Hoat Huyet Nhat Nhat Versus Tanakan for Treatment of Symptoms Related to the Insufficient Blood Supply to the Brain

Nhat Nhat Pharmaceutical

Status: Completed

Conditions: Insufficient Blood Supply to the Brain

Treatments: Drug: Hoat Huyet Nhat Nhat; Drug: Tanakan 40mg

Study type: Observational

Funder types: Industry

Identifiers

NCT03216681

HHNN-01

Details and patient eligibility

About

The purpose of this study is to evaluate the effectiveness of Hoat Huyet Nhat Nhat on the reduction of common symptoms related to the insufficient blood supply to the brain such as headache, vertigo, dizziness, sleep disorders and forgetfulness; compared with Gingko Biloba Egb761 (Tanakan) after 45 days of treatment

Enrollment: 750 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Male and Female more than 18 year old.
• With at least one of the symptoms related to the insufficient blood supply to the brain scored more than 5 out 10, on the Visual Analog Scale.
• Patients who will be using either Hoat Huyet Nhat Nhat or Tanakan following doctor's prescription or by patients own decision.
• Sign the informed consent form

Exclusion criteria

• Use of any medications for treatment of the insufficient blood supply to the brain in the last 3 months

Trial design

750 participants in 2 patient groups

Hoat Huyet Nhat Nhat

Description:

Administered orally twice a day, 2 tablets each time, for 45 days.

Treatment:

Drug: Hoat Huyet Nhat Nhat

Tanakan 40mg

Description:

Administered orally three times a day, one tablet each time, for 45 days.

Treatment:

Drug: Tanakan 40mg